HOME >> MEDICINE >> NEWS
UPMC begins study of heart support device as a bridge to transplantation

PITTSBURGH, May 21 Doctors at UPMC have begun a study using an investigational cardiac device, the VentrAssist Left Ventricular Assist System (LVAD) to see whether it can be used safely and effectively in patients with end-stage heart failure.

The study hopes to enroll 30 patients overall for the multi-center feasibility trial throughout nine centers in the United States. Five patients at UPMC have received the device so far, and one has successfully received a heart transplant after waiting for nearly three months on the pump, two of which were spent at home on the device.

"The VentrAssist LVAD presents us with a third-generation mechanical solution for end-stage congestive heart failure that approaches the goal of minimal interference with a patient's life. In a subsequent study with this pump, we will focus on support for transplant candidates as well as permanent use for those who do not qualify for heart transplantation, hopefully demonstrating its advantages over previous technology," said Robert Kormos, M.D., co-director of heart transplantation, director of the artificial heart program, medical director of the McGowan Institute for Regenerative Medicine and professor of surgery, division of cardiothoracic surgery at the University of Pittsburgh School of Medicine.

The VentrAssist LVAD is a mechanical blood pump that is implanted in the body to assist the heart to pump blood around the body for people with end-stage heart failure. It is still an experimental investigational device that has been approved by the U.S. Food and Drug Administration only for the purposes of the study. The blood pump is made of titanium and weighs just over half a pound, compared to the 5 pounds of older pumps. The implanted blood pump is connected to the heart and the aorta by two tubes called cannulae. Blood is drawn directly from the left ventricle and returned to the aorta. The VentrAssist LVAD works in tandem with the natural heart and an ext
'"/>

Contact: Maureen McGaffin
McGaffinME@upmc.edu
412-647-3555
University of Pittsburgh Medical Center
21-May-2007


Page: 1 2

Related medicine news :

1. Mercurys link to heart disease begins in blood vessel walls
2. Johns Hopkins begins aggressive screening for superbugs in children
3. Brain structure changes years before memory loss begins
4. Response to anti-HIV therapy improved if treatment begins six months after preventive regimen
5. Researchers find nicotine withdrawal begins quickly
6. NIAID begins clinical trial of West Nile virus vaccine
7. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
8. Penn study finds pro-death proteins required to regulate healthy immune function
9. New study shows promise in reducing surgical risks associated with surgical bleeding
10. New study counts the economic cost of persistent pain in Australia
11. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... , ... August 31, 2020 , ... ... support services to dental groups in the United States, today announced the grand ... of Beaumont, CA. , Patients will enjoy convenient hours, a comfortable office, ...
(Date:8/31/2020)... ... August 31, 2020 , ... A Cure for Covid-19 “PTS” with Mediation & Hypnosis ... are in a state of panic, experiencing deep anxiety, immense stress, and right now are ... is timely when most people on the planet are experiencing a great degree of emotional ...
(Date:8/31/2020)... ... August 31, 2020 , ... Dr. Chang has ... with autism and other developmental disabilities, as well as supporting staff in caring ... with autism, school consultation, and staff development. She joined the company in 2015 ...
(Date:8/29/2020)... ... ... When professor and author Randy Pausch was diagnosed with pancreatic cancer, he accepted his ... however, he put together a final lecture in Carnegie Hall in which he offered ... and turned it into something that inspired millions of people worldwide. This inclination to ...
(Date:8/28/2020)... ... 28, 2020 , ... WHAT , Hespiro™ is a new ... conditions, including COVID-19, while reducing the need for scarce mechanical ventilators. It not ... and scrubs it free of carbon dioxide in a completely closed “rebreather” system, ...
Breaking Medicine News(10 mins):
(Date:9/3/2020)... ... September 03, 2020 , ... Q&J Face ... https://www.colorado.edu/lab/vance/masks ), an aerosol and engineering lab, conducted tests on Q&J’s personal face ... COVID-19 virus than many other masks. Q&J face masks have both mechanical filtering ...
(Date:9/2/2020)... ... September 02, 2020 , ... Rigaku Analytical Devices ... discussion among industry professionals about successes and challenges of making changes to their ... Review and will take place on October 15, 2020 at 10:00am PDT ...
(Date:9/1/2020)... (PRWEB) , ... September 01, 2020 , ... ... laboratory technologies, will host the Agilent Science and Technology Virtual Symposium 2020 ... two-day symposium, Agilent will open a suite of Live webinars and Networking sessions, ...
Breaking Medicine Technology:
Cached News: